new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Glaxo Group Limited
Glaxo Group Limited A Corporation
  

Glaxo Group Limited patents

Bulk PDF Downloads
Recent patent applications related to Glaxo Group Limited. Glaxo Group Limited is listed as an Agent/Assignee. Note: Glaxo Group Limited may have other listings under different names/spellings. We're not affiliated with Glaxo Group Limited, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Glaxo Group Limited-related inventors




Date Glaxo Group Limited patents (updated weekly) - BOOKMARK this page
12/01/16 new patent  Novel processes
11/17/16Antigen binding proteins
11/03/16Dentifrice composition comprising spherical fused aluminum oxide particles
10/20/16Novel compounds
09/29/16Methods for controlling protein glycosylation
08/18/16Novel polymorphs and salts
08/11/16Dentifrice composition comprising sintered hydroxyapatite
07/28/16Novel dentifrice composition
07/21/16Antigen-binding constructs
07/07/16Antigen binding proteins
06/16/16Device housing for an aerosol container
06/09/16Chemical process
06/02/16Pharmaceutical metered dose inhaler and methods relating thereto
04/07/16Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
03/17/16Substituted diketopiperazines and their use as oxytocin antagonists
03/17/16Novel crystal form
03/17/16Anti-serum albumin binding variants
03/10/16Sample plate for an x-ray powder diffraction apparatus
02/04/16Novel compounds
01/28/16Antibodies against amyloid-beta peptide
01/14/162 - (azaindol-2-yl) benz imidazoles as pad4 inhibitors
01/14/16Production methods
01/07/16Muscarinic acetylcholine receptor antagonists
12/24/15Method of producing a protein
12/17/15Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor
12/17/15Ligands that bind tgf-beta receptor ii
12/03/15Polypeptide loaded poca nanoparticles for oral administration
12/03/15Inhaler device
11/19/15Guide device for a liquid dispenser
11/19/15Novel compounds
11/05/15Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases
10/29/15Composition comprising a single variable domain and camostat mesylate (cm)
10/29/153 -amino- pyrazole derivatives useful against tuberculosis
10/22/15Combination of levocabastine and fluticasone furoate for the treatment of inflammatory and/or allergic conditions
10/22/15Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
10/22/15Novel polymorphs and salts
10/22/152-substituted cephem compounds
10/08/15Anti-serum albumin binding variants
09/24/15Formulation for retinoid-containing soft gelatin capsules
09/10/15Container system for mixing and dispensing a drink
08/27/15Muscarinic acetylcholine receptor antagonists
08/20/15Chemical process
07/30/15Liquid droplet dispenser
07/30/15Compositions comprising an antibody and camostat mesylate (cm)
07/30/15Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists
07/30/15Sample plate for an x-ray powder diffraction apparatus
07/23/15Novel use
07/23/15Inhibitors of bromodomain-containing protein pcaf for the treatment of autoimmune and inflammatory diseases or for the treatment of cancer
07/16/15Novel ligand
07/02/15Silica abrasive-free dentifrice composition
06/18/15Novel compounds
06/11/15Novel compounds
04/23/15Re-sealable container
04/16/15Substituted diketopiperazines and their use as oxytocin antagonists
04/09/15Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp-pla2
04/02/15Modified antigens
04/02/15Aggregate nanoparticulate medicament formulations, manufacture and use thereof
03/19/15Benzofuran compounds for the treatment of hepatitis c virus infections
03/19/15Novel compounds
03/05/15Antigen binding proteins to oncostatin m (osm)
03/05/15Novel compounds
02/12/15Novel compounds
01/01/15Novel composition
12/25/14Tricyclic compounds, preparation methods, and their uses
12/18/14Muscarinic acetylcholine receptor antagonists
Patent Packs
11/13/14Methods of treatment and prevention of eye diseases
10/23/14Use of organic solvent nanofiltration and liquid-liquid chromatography for the recovery of pharmaceutical products
09/25/143 -amino- pyrazole derivatives useful against tuberculosis
08/14/14Modified proteins and peptides
08/14/14Drug fusions and conjugates with extended half life
07/24/14Antigen binding constructs
07/24/14Formulation for retinoid-containing soft gelatin capsules
07/17/14Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
07/10/14Drug fusions and conjugates
07/03/14Methods for selecting protease resistant polypeptides
06/26/142,3-dihydroimidazo[1 ,2-c] pyrimidin-5(1 h)-one compounds use as lp-pla2 inhibitors
06/12/14Medicament dispenser
05/22/14Anti-serum albumin biding variable domains
05/01/14Dry powder inhaler compositions
04/24/14Tumour necrosis factor receptor 1 antagonists
Patent Packs
04/24/14Novel combination of therapeutic agents
04/24/14Compounds
04/17/14Humanized anti-il-18 antibodies
04/17/14Bcma (cd269/tnfrsf17) - binding proteins
03/20/14Manifold for use in medicament dispenser
03/20/14Muscarinic acetylcholine receptor antagonists
02/27/14Method for inhibiting binding to b-cell receptor
02/27/14Substituted diketopiperazines and their use as oxytocin antagonists
02/20/14Antibodies
02/20/14N-cyclobutyl - imidazopyridine - methylamine as trpv1 antagonists
02/06/14Tetrahydropyrazolo [1,5-a] pyrimidine as anti-tuberculosis compounds
01/23/14Novel composition
01/23/14Method of treatment
01/02/14Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
01/02/14Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
12/26/13Process for the preparation of retigabine
12/19/13Methods of identifying a patient population
11/28/13Novel uses
11/28/13Compounds
11/21/13Novel antigen binding proteins
11/14/13Ligands that bind tgf-beta receptor ii
10/10/13Process for the preparation of atovaquone
10/03/13Benzamide derivatives as ep4 receptor agonists
09/26/13Antigen binding proteins to oncostatin m (osm)
09/26/13Novel compounds
09/12/13Benzofuran compounds for the treatment of hepatitis c virus infections
08/29/13Method of treatment based on atad2 inhibitors
08/22/13Method of determining cleanliness
08/22/13Dispensing device
08/22/13Pyrazole compounds acting against allergic, inflammatory and immune disorders
Social Network Patent Pack
08/15/13Method of treatment
08/08/13Pyrazole compounds acting against allergic, immune and inflammatory conditions
08/08/133 -amino- pyrazole derivatives useful against tuberculosis
08/01/13Magi polynucleotides, polypetides, and antibodies
07/25/13Fusions and conjugates of insulinotropic agents
05/23/13Substituted diketopiperazines as oxytocin antagonists
05/16/13Machine and pharmaceutical and pharmaceutical-like product assembly
05/02/13Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
04/25/13Substituted diketopiperazines and their use as oxytocin antagonists
03/28/13Novel use
Patent Packs
02/28/13Amino-quinolines as kinase inhibitors
02/14/13Sample plate for an x-ray powder diffraction apparatus
02/14/137-(lh-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors
01/31/13Compounds
01/31/13Muscarinic acetylcholine receptor antagonists
01/24/13Voltage-gated sodium channel blockers
01/10/13Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
12/13/12Compounds which have activity at m1 receptor and their uses in medicine
12/06/12Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
12/06/12Compounds which have activity at m1 receptor and their uses in medicine
11/15/12Novel retigabine composition
11/01/12Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions
10/04/12Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity
09/27/12Novel device
09/27/12Benzpyrazole derivatives as inhibitors of pi3 kinases
09/20/12Novel compounds
09/20/12Indazole derivatives as pi 3-kinase
09/13/12Novel compounds
08/16/12Dosing regimen
08/09/12Novel compounds
06/21/12Medical use
06/21/12Muscarinic acetylcholine receptor antagonists
06/21/12Antibiotic drug
06/14/12Piperidine derivatives used as orexin antagonists
06/14/12New medical use
05/24/12Anti-il-23 immunoglobulins
05/24/12Ligand that bind tgf-beta receptor rii
05/10/12Anti-serum album single variable domains
04/26/12Immunoglobulins
04/26/12S1p1 agonists comprising a bicyclic n-containing ring
Patent Packs
04/26/12Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/121,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/125-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
04/26/125-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
03/15/12Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
03/08/12Macrolides with anti-inflammatory activity
02/23/12Novel crystalline pharmaceutical product
02/23/12Process for the preparation of a biphenyl-2-yl carbamic acid ester
02/16/12Antibacterial composition comprising 4-isopropyl-3-methylphenol and zinc ions
02/16/123-azabicyclo [4.1.0] heptanes used as orexin antagonists
02/16/12Benzimidazoles which have activity at m1 receptor and their uses in medicine
02/16/12Benzimidazoles which have activity at m1 receptor and their uses in medicine
02/09/124-isopropyl-3-methylphenol for the treatment of inflammation
01/12/12Drug dispenser
01/05/12Substituted diketopiperazines and their use as oxytocin antagonists
12/29/11Pharmaceutical formulations comprising 4-hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
12/15/11Antigen-binding contructs
12/15/11Anitigen-binding constructs
11/24/11Novel compounds
11/17/11Substituted quinoline derivatives as h1 receptor antagonists
Social Network Patent Pack
11/10/11Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
11/10/11Tricyclic nitrogen compounds used as antibacterials
11/03/11Compounds
11/03/11Phenethanolamine derivatives for treatment of respiratory diseases
10/27/11Tricyclic compounds as glutamate receptor modulators
10/20/11Nozzle for a nasal inhaler
10/20/11Novel use
10/06/11Immunoglobulins
09/29/11Quinoline derivatives and their use as 5-ht6 ligands
08/04/11Salt of, and processes for the preparation of, 1-isopropyl-4-hexahydro-1h-1,4-diazepine
07/21/11Benzpyrazol derivatives as inhibitors of pi3 kinases
07/07/11Anhydrous crystal form of ovrepitant maleate
06/23/11Treatment of an autoimmune disease using il-18 antagonists
06/23/11Novel compounds
06/16/11Antibodies against amyloid-beta peptide
06/16/11Novel process, salts, composition and use
06/09/11Oral dosage form for controlled drug release
06/02/11Compounds which have activity at m1 receptor and their uses in medicine
05/19/11Pharmaceutical formulations
05/19/11Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
Social Network Patent Pack
03/17/11Drug dispenser
03/17/11Antigen binding proteins
03/17/11Triazole amide derivatives for use in therapy
03/10/11Encapsulation of biologically active agents
03/10/11Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators
02/24/11Adjuvant
02/24/11Pyrazole derivatives as p2x7 modulators
02/10/11Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor
01/27/11Compounds which potentiate the ampa receptor and uses thereof in medicine
01/13/11Tricyclic nitrogen compounds and their use as antibacterial agents
01/13/11Phenethanolamine derivatives for treatment of respiratory diseases
12/30/10Novel combination of therapeutic agents
12/23/10Novel compounds
12/16/10Novel use of alkyl phosphate esters
12/16/10Composition comprising an nk-1 receptor antagonist and an ssri for the treatment of tinnitus and hearing loss
12/16/10Monomaleate monohydrate salt of a 5ht1a receptor antagonist
12/09/10Dispensing device
12/09/10Method of treatment of allergic rhinitis
12/09/10Spiro compounds useful as antagonists of the h1 receptor
12/02/10Immunoglobulins
12/02/10Quinoline derivatives and their use as 5-ht6 ligands
12/02/10Novel compounds
12/02/10Novel compounds
11/18/10Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as p2x7 modulators
11/18/105-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators
11/11/10N-phenyl hydrazides as modulators of the ghrelin receptor
11/04/10Actuator for an inhaler
10/28/10Novel isoindol derivatives as ep4 receptor agonists
10/21/10Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
10/21/10N-[(3,5-dichlorophenyl)methyl]-2-(4-methyl-1-piperazinyl)-2-(1-naphthalenyl)ethanamide as ghrelin receptor modulator
Social Network Patent Pack
10/07/10Crystalline form of an antimalarial compound
10/07/10Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
09/23/10Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding
09/09/10Actuator for an inhaler
09/02/10Quinoline derivatives used to treat inflammatory and allergic diseases
08/26/10Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
08/26/10Glycine transport inhibitors
08/19/10Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
08/12/10Method and the application of powder material to substrates
08/12/10Piperazine derivative having affinity for the histamine h3 receptor
08/12/10Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
08/05/10Compounds
08/05/10I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders
07/29/10Novel compounds
07/22/10Compounds
07/22/10Process of amide formation
07/15/10Capsule
07/08/10Compounds
06/17/10Method and system for rapid phase luminescense spectroscopy analysis
06/17/10Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/10/10Apparatus for the disruption of animal cells
06/10/10Novel compounds
06/10/10Novel receptor antagonists and their methods of use
06/10/10Benzazepine derivatives for the treatment of neurological disorders
06/03/10Compounds which potentiate ampa receptor and uses thereof in medicine
06/03/10Tricyclic compounds as antibacterials
06/03/10Pyridine compounds for the treatment of prostaglandin mediated diseases
06/03/10Oxygen containing heterocycles as glycine transporter inhibiting compounds
05/27/10Prolinamide derivatives as modulators of voltage-gated sodium channels







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxo Group Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxo Group Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';